|
Arcturus Therapeutics Ltd. is #136 in rating Stock price grown in 3 years in United States. Arcturus Therapeutics Ltd. is #4 in rating Stock price grown in 3 years on NGM. Arcturus Therapeutics Ltd. is #72 in rating Stock price grown in a week on NGM. Arcturus Therapeutics Ltd. is #92 in rating Capitalization on NGM.
Stock exchange ratings on are compiled by the exchange itself online.The rating “Company capitalization” is a rating by capitalization. Capitalization is the total value of a company or the sum of the price of shares. The more shares the company has and the more expensive one share is, the higher the rating. It is the most expensive companies that make up the top of the list of rating companies by capitalization.
Arcturus Therapeutics Ltd. “Earnings per Share” rating is calculated after determining earnings per share upon publication of a financial report on the company's earnings. Earnings per share - an indicator calculated by the formula: all the company's profit for the reporting period by the number of shares in the company. The “earnings per share” rating is growing for those companies in which, as a rule, earnings per share are also growing.
Rating Arcturus Therapeutics Ltd. net income - a list of companies collected by the amount of total income. Net income is determined from the financial income of the company without taking into account the quantity and value of shares of this company. The top ranking of "Net income of the company" is usually headed by the largest and most profitable companies.
|
